Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01173263 · ClinicalTrials.gov registry record · NA
Effect of Bispectral Index (BIS) Titrated Propofol Sedation on Lower Esophageal Sphincter Pressures and Esophageal Function in Intensive Care Patients
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01173263 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 1 participants.
The verdict
NCT01173263, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Eligible patients will be allocated to receive propofol sedation titrated to 3 different Bispectral Index (BIS) levels in a random order. Primary hypothesis: Deepening propofol sedation - as determined by BIS - lowers esophageal pressure in critical care patients.
Interventions
- OTHER BIS 70 maintained
- OTHER BIS level 50
- OTHER BIS 35
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01173263
The ClinicalTrials.gov registry entry for NCT01173263 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BIS 70 maintained is the first listed.
NCT01173263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01173263 about?
NCT01173263 is a clinical study titled "Effect of Bispectral Index (BIS) Titrated Propofol Sedation on Lower Esophageal Sphincter Pressures and Esophageal Function in Intensive Care Patients". Eligible patients will be allocated to receive propofol sedation titrated to 3 different Bispectral Index (BIS) levels in a random order. Primary hypothesis: Deepening propofol sedation - as determined by BIS - lowers esophageal pressure in critical care patients.
What is the current status of trial NCT01173263?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2010-07. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01173263?
The interventions under investigation include: BIS 70 maintained (OTHER), BIS level 50 (OTHER), BIS 35 (OTHER).
Who is sponsoring clinical trial NCT01173263?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.